ABSTRACT Vitamin A is a well-established teratogen in all animal species. A number of case reports also suggest a teratogenic potential of vitamin A in humans. A possible teratogenic risk of dietary liver vitamin A intake, the kinetics of vitamin A and its metabolites in humans after intake of either a vitamin A supplement or a liver meal have been studied. Major differences were described for the kinetics of all-trans-retinoic acid (all-trans-RA), which occurred at much higher concentrations after supplementation than after liver consumption. Therefore, we investigated whether the intestine may be responsible for the differences in vitamin A metabolism after supplementation or liver feeding. We found that cytosolic fractions of porcine enterocytes oxidized retinol to all-trans-RA in vitro with a K m of 94 -96 mol/L and a V max of 7.9 -8.6 pmol/(min ⅐ mg protein). In an in vivo approach, the portal vein and the central vein (external jugular vein) of a pig were cannulated. In two subsequent experiments, the pig was given a vitamin A supplement or liver. Plasma samples were taken from portal and central veins. Comparison of retinoid levels in these veins indicated that all-trans-RA was already formed from supplemental vitamin A in the intestine and released into the systemic circulation. Two major metabolic pathways were additionally present in the pig, leading to the formation of glucuronides of all-trans-RA and retinol itself. Our results indicate that intestinal metabolism contributes to the elevated levels of all-trans-RA in the systemic circulation after supplementation with vitamin A, but not after consumption of liver.
Vitamin A alcohol (retinol) and its metabolites (retinoids; Fig. 1 ) are essential for various biological processes, such as vision, reproduction, cell growth and differentiation, and embryonic development (1) . In dermatology and oncology, retinoids are effective therapeutics (2). On the other hand, several case reports have indicated that vitamin A supplementation of 25,000 IU 3 vitamin A or more by pregnant women could result in birth defects (3) . The epidemiologic study of Rothman et al. (4) even suggests that intake of vitamin A at levels exceeding 10,000 IU/d may be associated with an increased teratogenic risk. A single meal of liver can contain a 10-to 30-fold higher amount of vitamin A. Our previous study (5) as well as the study of Buss et al. (6) showed that liver consumption led to a substantial increase of concentrations of active retinoid metabolites. However, in humans, systemic exposure to polar retinoids appeared remarkably different (6) after excess vitamin A intake from high doses of supplements or consumption of fried liver. After the intake of 500,000 IU vitamin A as a supplement, the area under the concentration-time curve (AUC) 4 values of all-trans-retinoic acid (RA) in plasma were significantly (P Ͻ 0.01, Student's t test) higher than after consumption of a liver meal with equal amounts of vitamin A (Fig. 2C) . On the other hand, plasma AUC of 13-cis-RA were in the same range (Fig. 2B) . The observed differences could not be explained exclusively by an elevated bioavailability of vitamin A from supplements because plasma AUC values of retinyl palmitate were comparable ( Fig. 2A) .
The oxidation of retinol to RA isomers via the intermediate retinal is the crucial step in the bioactivation of vitamin A because most effects of vitamin A are attributed to these metabolites. They mediate their effect by binding to nuclear receptors, namely, RAR (retinoic acid receptors) and RXR (retinoid X receptors) and activating them. All-trans-RA activates RAR subtypes. These receptors are dimer partners and act as ligand-activated transcription factors controlling the expression of a number of target genes (7) . It is likely that vitamin A exerts most of the beneficial, but also the teratogenic actions via bioactivation to retinoic acid isomers, which may then bind to these receptors.
In addition to the liver, many tissues can convert retinol to RA including brain, kidney, spleen, pancreas, skin, testis and lung (8 -11) . Cytosolic alcohol dehydrogenases but also microsomal enzymes of the short-chain alcohol dehydrogenase family are involved in the first metabolic step, the oxidation of retinol to retinal (12, 13) . Subsequently, retinal is converted to RA either by cytosolic retinal dehydrogenases (14, 15) or by cytochrome P 450 isozymes (16 -18) . Whether small intestinal enzymes might be involved in the metabolism of excess vitamin A remains speculative. Ingested retinyl esters, the major form of orally administered vitamin A, are cleaved intraluminally to retinol, which is then absorbed into the intestinal cells (19). There, retinol is immediately bound to a specific carrier protein, cellular retinol-binding protein type II (CRBP II), a protein that is expressed nearly exclusively in the intestine. Then, retinol is reesterified to retinyl esters by the specific enzymes lecithin-retinol acyl transferase and acyl CoA-retinol acyl transferase (20,21). Subsequently, retinyl esters are packed into chylomicrons and transferred into the lymphatic duct. Chylomicrons are reduced to chylomicron remnants in the systemic bloodstream (22) . These remnants are taken up by the liver and retinyl esters are subsequently stored in stellate cells of the liver (23). The uptake and reprocessing steps in the intestine might be saturable when an excess amount of vitamin A is given as a bolus, thus leading to a faster absorption of vitamin A from a supplement compared with a liver meal. Therefore, other metabolic pathways such as oxidation or glucuronidation may contribute to vitamin A metabolism. It was demonstrated recently that cytosolic fractions of human enterocytes can convert retinol to RA in the presence of NADPH (24) .
The goal of the present study was to explore the differences in the metabolic pattern of vitamin A in humans after either supplementation or liver consumption by a participation of intestinal enzymes in the oxidative processing of excessive amounts of vitamin A. Therefore, we examined by an in vitro approach whether subcellular fractions of the intestine could oxidize retinol to all-trans-RA. Additionally, an in vivo experiment was performed to examine whether excess vitamin A is metabolized to polar retinoids in the intestine and whether the metabolites generated are released into the portal vein, thus possibly contributing to systemic retinoid levels. Vitamin A metabolites were determined in plasma of the portal vein and of a systemic vein (external jugular vein, hereafter called central vein). The pig was chosen because pigs are omnivorous and their intestinal tract resembles that of humans in many aspects (25) .
MATERIALS AND METHODS
Chemicals and reagents. HPLC solvents were of gradient grade quality from Merck (Darmstadt, Germany). Unless otherwise mentioned, all other chemicals and reagents were from Sigma (Deisenhofen, Germany). Dithiotreitol was supplied by Pharmacia (Freiburg, Germany). ␤-Glucuronidase from Escherichia coli (EC 3.2.1.31; 2 ϫ 10 5 IU/L) was purchased from Boehringer Mannheim (Mannheim, Germany). Retinol, all-trans-RA, 13-cis-RA and retinyl palmitate were from Sigma. Retinyl esters other than retinyl palmitate were synthesized in our laboratory. Glucuronides of retinol and alltrans-RA were kindly provided by Dr. J. A. Olson and Dr. A. B. Barua (Ames, IA). 14-Hydroxy-4,14-retro-retinol (14-HRR) and anhydroretinol were gifts from Dr. F. Derguini and Dr. J. Buck (New York, NY). All other reference retinoids were gifts from Hoffmann-La Roche (Basel, Switzerland and Nutley, NJ).
Isolation of porcine enterocytes and preparation of cytosolic and microsomal fractions. Porcine small intestinal samples were obtained from a local slaughterhouse. Porcine enterocytes were isolated by the chelation-elution method according to the isolation of rat enterocytes described by Pinkus (26). The binding of enterocytes to the basal membrane was loosened by complexation with EDTA; the cells obtained were then rinsed out with phosphate buffer (pH 7.4) by repeated extension and contraction of the intestine. The isolated enterocytes were resuspended in phosphate buffer (pH 7.4) containing potassium chloride (100 mmol/L), EDTA (1 mmol/L) and dithiotreitol (1 mmol/L). Cytosolic and microsomal fractions were isolated using a differential centrifugation procedure described by Guengerich (27) . The enterocytes were homogenized using an Elvehjem teflon potter and subsequent ultrasonication. The homogenate was centrifuged for 20 min at 10,000 ϫ g, and the resultant supernatant was again centrifuged for 60 min at 100,000 ϫ g. The supernatant of this centrifugation step (representing the cytosolic fraction of the enterocytes) was collected and frozen at Ϫ80°C until further usage. The sediment was resuspended in phosphate buffer and centrifuged for 70 min at 100,000 ϫ g. The supernatant was discarded and the sediment (representing the microsomal fraction) was suspended in phosphate buffer (pH 7. In vitro experiments. The oxidative metabolism of all-transretinol to all-trans-RA was investigated by incubation of cytosolic or microsomal fractions of porcine enterocytes with various amounts of all-trans-retinol. In preliminary experiments, the incubation of alltrans-retinol with cytosolic fractions of porcine enterocytes was shown to be linear with respect to the duration of incubation (10 -30 min) and the protein concentration (0.5-2 g/L). The incubations were performed in duplicate in a total volume of 500 L containing In vivo experiments. The trial protocol for the in vivo experiments complied with NIH guidelines (29). A German Landrace pig (14 wk old; body weight, 23 kg) was supplied by the Center of Anatomy, Medical School Hannover (Hannover, Germany). After general anesthesia of the pig, the right external jugular vein was cannulated using a standard venous cannula (o.d., 2.1 mm; i.d., 1.4 mm) within a leading tube. After exteriorization, the cannula was fixed in the neck region. In a second step, a midline laparotomy was performed. In the upper jejunal mesentery a side branch of the upper mesenteric vein was exposed. Through this vein, a cannula leading to the portal vein was established. The portal vein cannula was exteriorized in the right flank of the abdomen and the laparotomy was closed by suturing the layers of the abdominal wall. The pig recovered from surgery within 3 d. Throughout the experiment, the pig was allowed to move in a wooden box (2.5 m 2 ) without fixation during blood sampling. The pig received twice daily ϳ700 g of a pelleted pig maintenance diet (NAFAG No. 9103 minipig maintenance diet, NAFAG, Gossau, Switzerland, for detailed information visit http: \\www.nafag.ch). The pig was deprived of food for 12 h before the experiments. Food was offered again 5-6 h after dosing.
Two subsequent experiments with 4-d washout periods were performed. In the first, the pig was given a vitamin A supplement containing a retinyl palmitate oil in water emulsion (A-Mulsin, Mucos Pharma, Geretsried, Germany) mixed with a small amount of food. The total dose administered was 430,000 IU vitamin A. In the second, the pig was fed 600 g liver. The vitamin A content of the liver was determined by HPLC. The amount of liver consumed contained a total dose of 667,000 IU vitamin A. In both experiments, blood samples were taken from the portal and central veins at different time intervals up to 24 h. Plasma was prepared and stored at Ϫ80°C until analysis. Retinoid metabolites were determined in portal and central vein plasma by HPLC and UV detection as described below. Areas under the plasma-concentration time curve values (AUC) were determined by the trapezoidal method (30) for 24 h after vitamin A intake. The maximum plasma concentrations (C max ) and time to maximum plasma concentrations (T max ) are the observed values.
HPLC analysis. Plasma samples as well as in vitro incubation mixtures were extracted with a threefold volume of isopropanol and underwent solid-phase extraction according to a method previously described (31) . A modification of the HPLC method described by Eckhoff and Nau (32) was used for determination of retinoids. This method uses a linear gradient formed from 57.5% methanol and 42.5% aqueous 60 mmol/L ammonium acetate to 95% methanol and 5% ammonium acetate within 11 min. To determine also retinol and retinyl esters in a single chromatographic run, the methanol percentage was increased to 100% at 11.2 min and further maintained at this level until 25 min (33) . The starting conditions of the gradient were reached again after 26 min. With this method, separation of retinyl palmitate and retinyl oleate was not possible. Detection was performed by monitoring the UV absorbance of the eluate at 340 and 356 nm simultaneously using a Shimadzu SPD 10 AV two wavelength detector (Kyoto, Japan). Peak eluates of putative retinoid glucuronides were collected, evaporated to dryness, redissolved in buffer, subjected to hydrolysis by ␤-glucuronidase and the resulting retinoids were rechromatographed. The procedure was described in detail by Sass and Nau (34) .
RESULTS
In vitro oxidation of all-trans-retinol by subcellular fractions of porcine enterocytes. The Michaelis-Menten kinetics of the all-trans-RA formation in cytosolic fractions of porcine enterocytes are presented in Figure 3A . The formation of all-trans-RA (dissolved either in ethanol or in DMSO) was concentration dependent. As shown in the Lineweaver-Burk plot (Fig. 3 B) , K m and V max of the reaction were determined to be 94 -96 mol/L and 7.9 -8.6 pmol/(min ⅐ mg protein), respectively, depending on the solvent used. The incubation of microsomal fractions of porcine enterocytes with retinol did not form detectable levels of oxidative metabolites under the experimental conditions used. RA isomers other than the all-trans form were not identified. The intermediate product, retinal, was detectable in trace amounts only.
In vivo kinetics and metabolism of vitamin A in the pig from supplement or liver. Predose levels of retinoids in plasma from portal and central veins are shown in Table 1 . Only retinol and retinyl palmitate/oleate (16:0/18:1) were detected in all plasma samples. Additionally, all-trans-RA and 13-cis-RA were detected before supplementation, but only at low levels. Retinol concentrations were slightly elevated at the start of the second experiment (liver feeding). Retinyl palmitate/oleate levels were markedly lower in the portal vein than in the central vein.
After intake of vitamin A as a supplement or a liver meal, several retinoid metabolites were detected in porcine plasma including retinol, retinyl esters (palmitate/oleate, stearate, linoleate and linolenate), anhydroretinol, 14-HRR, all-trans-RA, 9-cis-RA, 13-cis-RA (might include 9,13-di-cis-RA) (35), Table 2 summarizes the kinetic data. Considering the AUC and C max levels of retinol, retinyl palmitate/oleate and total retinyl esters in central vein plasma, it became apparent that the relative bioavailability of vitamin A from the liver feeding was ϳ70% [relative bioavailability ϭ AUC liver ⅐ dose supplement /(AUC supplement ⅐ dose liver )] of the supplement's availability. After liver feeding, the AUC and C max of retinyl palmitate/oleate and total retinyl esters were lower in portal vein plasma than in central vein plasma, whereas AUC and C max were comparable in central and portal veins after supplementation. Major differences between supplementation and liver feeding occurred with respect to phase I and phase II metabolism of vitamin A. After vitamin A supplementation, all-trans-RA concentrations in the portal vein were much higher than in the central vein. The concentration-time curve peaked at 1.75 h, then declined rapidly; there was a second peak at ϳ8 h, possibly reflecting enterohepatic circulation, whereas the all-trans-RA levels in central vein plasma were only marginally elevated at all time points (Fig. 4A) . Such a difference in all-trans-RA kinetics between central and portal veins did not occur after liver feeding (Fig.  4B) . On the other hand, the kinetics of 13-cis-RA did not exhibit major differences between central and portal veins or between supplementation and liver feeding (Fig. 4C and D,  respectively) . Glucuronidation of retinoic acid moieties to RAG also occurred. AUC of RAG in portal vein plasma were higher than those in central vein plasma, although only marginally ( Fig. 4E and F, respectively) . The major metabolic pathway of vitamin A, however, was the direct glucuronidation of retinol, yielding ROG. The AUC of ROG were approximately twofold higher after supplementation compared with after consumption of liver, whereas C max levels were fiveto sevenfold higher ( Fig. 4G and H, respectively) . Additionally, a marked difference in ROG kinetics was obvious between portal and central veins after supplementation. ROG levels were higher in portal vein than in central vein after supplementation, but not after liver feeding.
13-cis-4-oxo-RA, retinoyl ␤-D-glucuronide (RAG) and retinyl ␤-D-glucuronide (ROG).
To summarize, the major differences in metabolism of vitamin A in the pig after supplementation and liver consumption are illustrated in Figure 5A and B, respectively. In Figure  5A , HPLC chromatograms of a portal vein plasma sample (upper trace) and a central vein plasma sample (lower trace) both taken 1.75 h after supplementation (at T max for all-trans-RA) are overlaid. Portal vein levels of retinoid metabolites were greater, with the major differences apparent for alltrans-RA (peak 5) and ROG (peak 2). The peak eluting at ϳ1 min after all-trans-RA in portal vein plasma could not be identified. In Figure 5B , HPLC chromatograms of a portal vein plasma sample taken 1.75 h after supplementation (upper trace) and 2.5 h after liver feeding (lower trace), which are representative for the respective T max of all-trans-RA, are shown. Again, all-trans-RA and ROG levels were higher after supplementation compared with after liver consumption.
DISCUSSION
In vitro studies have demonstrated that soluble alcohol dehydrogenases as well as other dehydrogenases can synthesize all-trans-RA (10,36 -38). The formation of all-trans-RA from unbound retinol occurred in the presence of either cytosolic fractions or microsomal fractions, mainly from liver (10, 17, 36, 37, 39, 40) . Additionally, conversion of retinal to RA was described in presence of human cDNA-expressed P 450 enzymes (18) . In most tissues, retinol does not occur in its unbound form, but bound to CRBP I. The oxidation of unbound as well as CRBP I bound retinol was examined with cytosolic fractions from calf liver (41) . The K m values for unbound and CRBP I bound retinol were 7.1 and 8.4 mol/L, respectively. The V max value for the conversion of free retinol [15 pmol/(min ⅐ mg protein) was higher than that for CRBP I bound retinol [10 pmol/(min ⅐ mg protein)]. Because the dissociation constant for the retinol-CRBP I complex is 10 Ϫ8 mol/L and K m values were in the same range, the dissociation of the retinol-CRBP I complex should not be a prerequisite for the oxidation of retinol. It was therefore concluded that CRBP I might serve as a channel protein for retinol metabolizing enzymes (42) . In the gastrointestinal (GI) tract, the functionally diverse CRBP type II exists almost exclusively (43, 44) . In vivo experiments in rats have shown that the molar ratio of unesterified retinol to CRBP II in the GI tract changed after oral administration of high vitamin A doses (given as retinyl acetate) from Ͻ1 in control groups to 3-19 in treated groups (45) . It can therefore be concluded that large amounts of unbound retinol are present in the GI tract after administration of a vitamin A bolus. This unbound fraction of retinol might be metabolized by phase I or phase II enzymes.
In the present work, the in vitro oxidation of retinol to all-trans-RA was demonstrated in cytosolic fractions of porcine enterocytes. A K m of 94 -96 mol/L and a V max of 7.9 -8.6 pmol/(min ⅐ mg protein) was determined. The results of the in vitro experiments indicated that retinol is a substrate for cytosolic enzymes of the porcine intestinal mucosa, although with a weak affinity. Due to the high K m of the reaction, it can be concluded that nonspecific enzymes are involved, which metabolize retinol only at high local concentrations, but with a turnover comparable to those rates described in the literature (41) .
The differences in oxidative vitamin A metabolism in humans observed in the study of Buss et al. after intake of 500,000 IU vitamin A as a supplement or a liver meal raised the question whether intestinal metabolism of retinol to RA moieties and subsequent release of polar retinoids into the systemic circulation after a bolus of vitamin A as a supplement might be responsible for that phenomenon. In our in vivo experiment in a pig, amounts of vitamin A comparable to those of Buss et al. (6) were administered either as a supple- ment (430,000 IU) or liver (667,000 IU). It was clearly demonstrated that retinol is metabolized to all-trans-RA already in the intestine. However, contrary to the human situation, other metabolic pathways dominated, yielding glucuronides of alltrans-RA and retinol. We assume that in humans, higher amounts of all-trans-RA would have been formed intestinally after vitamin A supplementation. The recent finding that human intestinal enterocytes can oxidize retinol to alltrans-RA with a K m of 15 mol/L and a V max of 2 pmol/ (min ⅐ mg protein) (24) supports this hypothesis.
In contrast to retinyl esters, which are transported in chylomicrons via the lymphatic duct, polar metabolites of retinol are transported via the portal vein. As a consequence, portal vein plasma levels in the pig were higher than the corresponding levels in the central vein after vitamin A supplementation, at least for all-trans-RA and ROG.
To date, in vivo experiments describing the role of the GI tract in the metabolism of vitamin A have focused mainly on the esterification of absorbed retinol and the transport of resulting retinyl esters via the lymphatic duct (46 -48) . Only in some experiments was the role of the GI tract in the oxidative metabolism of vitamin A studied. In ferrets, alltrans-RA was detected in the intestinal mucosa after perfusion of small intestinal segments with either ␤-carotene or retinal (49) . After daily doses of 20 mg retinyl acetate to rats over 14 d, all-trans-RA, 13-cis-RA, all-trans-RAG and more polar metabolites were detected in the intestinal mucosa (50) . Because the bile duct was cannulated shortly before termination of the experiment, the authors concluded that polar metabolites must have been generated in the intestine. However, it cannot be excluded that polar metabolites might have been generated in the liver and subsequently transported via the systemic circulation to intestinal tissues. Therefore, portal and central vein plasma levels of retinoids were compared in our in vivo study.
In summary, our study demonstrated that all-trans-RA is formed after incubation of cytosolic fractions of porcine enterocytes with retinol. The in vivo experiment in a pig showed that retinol is already metabolized in the intestine to polar phase I and phase II metabolites, which are subsequently released into the portal vein. The major metabolic pathways of vitamin A in porcine intestine are summarized in Figure 6 . These findings raise the question whether a threshold of vitamin A intake exists in humans at which the intestine contributes to systemic exposure of putative teratogenic vitamin A metabolites.
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FIGURE 6
Proposed intestinal metabolic pathways of vitamin A after supplementation of a German Landrace pig. Retinyl esters (RE) are hydrolyzed intraluminally and retinol (ROH) is taken up into the enterocyte. There, the excess retinol is bound to cellular retinol-binding protein type II (CRBP II) and undergoes reesterification. Unbound retinol might be esterified to RE or metabolized to all-trans-retinoic acid (alltrans-RA), 13-cis-RA, retinyl ␤-D-glucuronide (ROG) or retinoyl ␤-Dglucuronide (RAG). RE are packed into chylomicrons and reach the central vein via the lymphatic duct. Metabolites of retinol enter the portal vein bloodstream and reach the central vein following passage through the liver.
